Notably, we assume that this tumor suppressor role (suggested to be intensified by this polymorphism) might reduce or overcome the oncogenic role of RTN4/Nogo isoforms induced by PI3K/AKT and MAPK/ERK activation. This evidence concerns the gene RTN4 and neoplasm.